Compare LMB & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMB | SENS |
|---|---|---|
| Founded | 1901 | 1996 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Engineering & Construction | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.3M | 496.0M |
| IPO Year | 2014 | 2014 |
| Metric | LMB | SENS |
|---|---|---|
| Price | $50.32 | $8.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $116.67 | $18.38 |
| AVG Volume (30 Days) | 415.9K | ★ 664.3K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.68 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $646,804,000.00 | $16,389,000.00 |
| Revenue This Year | $15.96 | $74.15 |
| Revenue Next Year | $5.90 | $58.60 |
| P/E Ratio | $64.22 | ★ N/A |
| Revenue Growth | ★ 24.68 | 19.85 |
| 52 Week Low | $40.74 | $0.41 |
| 52 Week High | $114.95 | $10.15 |
| Indicator | LMB | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 45.30 | 55.02 |
| Support Level | $40.74 | $5.13 |
| Resistance Level | $84.79 | $10.07 |
| Average True Range (ATR) | 1.87 | 0.55 |
| MACD | 1.82 | -0.18 |
| Stochastic Oscillator | 80.50 | 20.01 |
Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.